Boundless Bio Inc (BOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,587 | 40,214 | 31,363 | 25,143 | 23,706 |
| Marketable Securities | 125,527 | 126,921 | 147,927 | 79,737 | 97,046 |
| TOTAL | $154,390 | $170,449 | $183,132 | $112,161 | $124,204 |
| Non-Current Assets | |||||
| PPE Net | 4,321 | 3,959 | 3,739 | 2,418 | 2,573 |
| Other Non-Current Assets | 47,698 | 685 | 1,332 | 2,498 | 3,117 |
| TOTAL | $52,019 | $4,644 | $5,071 | $4,916 | $5,690 |
| Total Assets | $206,409 | $175,093 | $188,203 | $117,077 | $129,894 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,354 | 7,041 | 6,066 | 8,182 | 4,266 |
| Accrued Expenses | 2,781 | 2,848 | 2,054 | 939 | 2,898 |
| TOTAL | $8,135 | $10,010 | $8,957 | $10,644 | $9,359 |
| Non-Current Liabilities | |||||
| TOTAL | $47,632 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $55,767 | $10,010 | $8,957 | $10,644 | $9,359 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,300 | 22,300 | 22,255 | 22,255 | N/A |
| Common Shares | 2 | 2 | 2 | N/A | N/A |
| Retained earnings | -201,472 | -185,024 | -168,515 | -151,539 | -136,109 |
| Other shareholders' equity | 121 | 236 | -64 | 247,596 | 247,657 |
| TOTAL | $150,642 | $165,083 | $179,246 | $106,433 | $120,535 |
| Total Liabilities And Equity | $206,409 | $175,093 | $188,203 | $117,077 | $129,894 |